BiotechTube
Home/Incyclix Bio/Andrew Beelen, MD
AB

Andrew Beelen, MD

Vice President of Clinical Development

Incyclix Bio

Therapeutic Areas

Oncology

Incyclix Bio Pipeline

DrugIndicationPhase
INX-315CDK4/6 Inhibitor Resistant ER+/HER2- Breast Cancer; CCNE1-Amplified Solid TumorsPhase 1/2

Leadership Team at Incyclix Bio

PR
Patrick Roberts, Pharm.D., Ph.D.
Chief Executive Officer, Co-Founder
JS
Jay Strum, Ph.D.
Chief Scientific Officer, Co-Founder
JB
John Bisi, B.S.
Senior Vice President of Research and Development, Co-Founder
KM
Karen Makhuli
Vice President, Clinical Operations
View full Incyclix Bio profile